TCI Wealth Advisors, Inc. - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q1 2023$527
-6.2%
100
-50.0%
0.00%
Q4 2022$562
-43.8%
2000.0%0.00%
Q3 2022$1,0000.0%2000.0%0.00%
Q2 2022$1,0000.0%2000.0%0.00%
Q1 2022$1,000
-83.3%
200
-75.7%
0.00%
-100.0%
Q4 2021$6,000
+200.0%
822
+730.3%
0.00%0.0%
Q1 2021$2,000990.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders